Professional Summary
Professional Overview
Marc Hoffman is an accomplished healthcare executive with over 25 years of experience in the pharmaceutical and biotechnology industries. As the Chief Medical Officer at Rockwell Medical, Inc., he provides strategic leadership and medical expertise to drive the company's clinical development and medical affairs initiatives. With a strong background in medical affairs, regulatory affairs, and global product safety, Hoffman is recognized for his ability to navigate complex regulatory environments and deliver innovative medical solutions.
Experience Summary
Current Role
As the Chief Medical Officer at Rockwell Medical, Inc., Hoffman is responsible for overseeing the company's medical strategy, clinical trial design, and regulatory submissions. He collaborates closely with cross-functional teams to ensure the successful development and commercialization of Rockwell's products, which are focused on addressing unmet needs in the nephrology and critical care therapy areas.
Career Progression
Hoffman's extensive career includes senior leadership roles at several leading pharmaceutical and clinical research organizations. Prior to joining Rockwell Medical, he served as the Chief Medical Officer at Celerion, where he was instrumental in expanding the company's global footprint and enhancing its clinical trial execution capabilities. Hoffman also held Chief Medical Officer positions at Patient I.P. and Theorem Clinical Research, where he led the development and implementation of innovative medical strategies.
Earlier in his career, Hoffman held various executive positions at Covance, Hospira, and Baxter Healthcare, where he spearheaded global medical affairs, regulatory affairs, and product safety initiatives. His diverse industry experience and deep understanding of the pharmaceutical landscape have positioned him as a respected thought leader in the field.
Academic Background
Hoffman holds a Doctor of Medicine (M.D.) degree from the University of Illinois College of Medicine and is board-certified in Internal Medicine and Oncology. He has also completed various executive leadership programs and maintains active affiliations with several professional organizations, including the American Medical Association and the American College of Physicians.
Areas of Expertise
- Medical strategy and clinical development
- Regulatory affairs and product safety
- Global medical affairs and product commercialization
- Pharmaceutical and biotechnology industry leadership
- Cross-functional team collaboration and management
Professional Impact
Throughout his career, Hoffman has made significant contributions to the pharmaceutical and biotechnology industries. He has successfully led the development and approval of numerous drugs and medical devices, working closely with regulatory bodies to ensure compliance and patient safety. Notably, Hoffman's work at Celerion, Patient I.P., and Theorem Clinical Research has helped to advance the clinical research landscape, improving the efficiency and quality of clinical trials.
Conclusion
With his extensive experience, medical expertise, and strategic leadership, Marc Hoffman is well-positioned to drive Rockwell Medical's clinical and medical affairs initiatives, contributing to the company's mission of improving patient outcomes in the nephrology and critical care therapy areas. His proven track record of success and industry-recognized expertise make him a valuable asset to the organization and a respected leader in the healthcare sector.
